| identifier: | 1816959 |
| description: |
epitope description:alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-beta-D-Gal-(1->4)-beta-beta-D-Glc-(1<->1')-Cer
host organism:Homo sapiens
|
| aggregation: |
instance of dataset
|
| availability: |
available
|
| primaryPublications: |
8636426 |
| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/1018082 |
| landingPage: |
http://www.iedb.org/assay/1816959 |
| type: |
Literature
|
| publicationVenue: |
J Clin Invest
|
| dates: |
1996
|
| study type: | b cell assays |
| subject species: |
| fullName: |
H J Willison
G M O'Hanlon
G Paterson
J Veitch
G Wilson
M Roberts
A Vincent
|
| method: |
western blot
|
| name: |
A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |